Showing results (171-180 of 265) with videos related to

Sort By:
Pageof 27
Clinical Rheumatology|October 24, 2025
Changes in weight associated with tumor necrosis factor inhibition in psoriatic arthritis: results from a retrospective cohort studyFadi Kharouf, Barry J Sheane, Shangyi Gao, et al.
Dental Materials : Official Publication of the Academy of Dental Materials|September 19, 2022
Glass-ionomer and calcium silicate-based cements interactions with human dentine in health and disease: Two-photon fluorescence microscopy and Raman spectroscopy analysisShara Sajini, Amre R Atmeh, Avijit Banerjee, et al.
Arthritis Care & Research|December 4, 2014
Minimal disease activity and anti-tumor necrosis factor therapy in psoriatic arthritisAmir Haddad, Arane Thavaneswaran, Ioana Ruiz-Arruza, et al.
Medical Image Analysis|December 27, 2011
Re-localisation of a biopsy site in endoscopic images and characterisation of its uncertaintyBaptiste Allain, Mingxing Hu, Laurence B Lovat, et al.
Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|October 1, 2010
A system for biopsy site re-targeting with uncertainty in gastroenterology and oropharyngeal examinationsBaptiste Allain, Mingxing Hu, Laurence B Lovat, et al.
Arthritis Care & Research|April 1, 2011
Incidence of arthritis in a prospective cohort of psoriasis patientsLihi Eder, Vinod Chandran, Hua Shen, et al.
Biometrics|September 16, 2024
Semi-parametric benchmark dose analysis with monotone additive modelsAlex Stringer, Tugba Akkaya Hocagil, Richard J Cook, et al.
Seminars in Arthritis and Rheumatism|December 31, 2020
Malignancy in psoriatic disease: Results from prospective longitudinal cohortsAri Polachek, Anastasiya Muntyanu, Ker-Ai Lee, et al.
The Journal of Rheumatology|May 3, 2013
Soluble biomarkers associated with response to treatment with tumor necrosis factor inhibitors in psoriatic arthritisVinod Chandran, Hua Shen, Remy A Pollock, et al.
Clinical Lymphoma & Myeloma|June 15, 2007
Clinical utility of biochemical markers of bone metabolism for improving the management of patients with advanced multiple myelomaAllan Lipton, Richard J Cook, Robert E Coleman, et al.
Pageof 27